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Detection of hepatitis B virus DNA in oral ﬂuid by using an
optimised nested PCR
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Background: Conventionally the detection of hepatitis B
virus (HBV) DNA is carried out on serum using commercial or
in house PCR assays. Oral ﬂuid obtained by use of commer-
cial collection devices offers several advantages compared
to venepuncture: it is non invasive, painless, safe and less
expensive.
Methods: Seventy-three HBV DNA positive and 74 HBV
DNA negative paired serum/oral ﬂuid samples, drawn from
patients visiting university hospitals, were analysed. The
detection of HBV DNA in oral ﬂuid was carried out through
an optimised nested PCR with a 95% detection limit of
457 copies/ml
Results: A clinical sensitivity and speciﬁcity of 69.9%
(95%CI: 58.6%-79.2%) and 100% (95%CI: 95.1%-100.0%)
respectively was achieved. A statistically signiﬁcant asso-
ciation was found between the serum HBV DNA viral load
and the detection of HBV DNA in oral ﬂuid (p < 0.001). In
samples with a minimum concentration of 105 copies/ml
(high viraemia), it was possible to detect the virus in oral
ﬂuid in 91.8% (95%CI:80.8%-96.8%) of the cases. A concen-
tration of 105 copies/ml being considered as the minimum
level needed for the transmission of HBV via needlestick or
mucosal scratch, the optimised nested PCR could be used
in epidemiological surveys for mapping of active replicating
carriers.
Conclusion: An optimised nested PCR for HBV detection,
with a 95% detection limit of 457 copies/ml and a sensitivity
of 91.8% in patients with a minimum serum concentration of
105 copies/ml, was developed. The use of serum remains the
golden standard for individual diagnosis, monitoring of anti-
viral treatment or detection of occult infections. However,
oral ﬂuid sampling by oracol collection device offers through
all its advantages versus venepuncture a good alternative in
epidemiological and surveillance surveys.
doi:10.1016/j.ijid.2008.05.1335
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Screening for Inﬂuenza A H5N1 Haemagglutinin and Neu-
ramidase Mutations Using the New Alignment & Mutation
Analysis Tool in Bionumerics
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Vauterin
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The haemagglutinin (HA) and neuramidase (NA) genes are
considered to be responsible for the major part of the anti-
genic variability of inﬂuenza A viruses. Reportedly, speciﬁc
amino acid changes might even serve as molecular markers
for the pandemic potential of avian inﬂuenza isolates.
We recently developed an Alignment & Mutation Analysis
tool as an extension library for the BioNumerics software.
Here, we illustrate the use of this versatile and power-
ful tool with publicly available sequences and trace ﬁles.
The latter were automatically assembled into contigs and
imported with the batch assembly plugin. Optimized set-
tings for trimming and assembly minimized manual editing.
Strain information was parsed along with the import and all
data were stored in a single relational database.
Using this plugin, we were able to assemble 22,000
inﬂuenza A genome sequence trace ﬁles from the NCBI Trace
Archive (http://0-ww.ncbi.nlm.nih.gov.catalog.llu.edu/
Traces/trace.cgi) in less than 30minutes. For the HA and
NA gene sequences of inﬂuenza A virus serotype H5N1,
a multiple alignment was created and the nucleic acid
sequences were translated into amino acids. Mutations
were searched relative to a consensus sequence, which
made ‘‘hot spots’’ for mutations to become immediately
apparent. For each mutation, its position, type (silent,
missense, indel), nucleotide change and amino acid change
was listed. When browsing through the mutation list, the
cursor jumps automatically to the corresponding position
on the alignment and curves, allowing the researcher to
visually evaluate the mutation in its context.
Overall, performing the complete mutation analysis
within a single software package offers much added ﬂexi-
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Reliable and fast assays are prerequisite for rapidly
identifying infectious agents such as emerging viruses,
zoonotically transmitted or otherwise rare and unusual
viruses in order to take appropriate epidemiologic actions
and/or to choose the best treatment. However, detection
and identiﬁcation of viruses without speciﬁc knowledge
about their genome can be challenging.
We developed an assay that combines virus capsid prepa-
ration with generic PCR. The ﬁrst step is the physical and
biochemical puriﬁcation of a given sample by targeted
digestion of contaminating host nucleic acids. This is fol-
lowed by a degenerate oligonucleotide primer (DOP) PCR.
The primer population is optimized for the detection of
virus-sized genomes. Products can be identiﬁed by cloning
and sequencing or by subjecting the PCR products to high
throughput sequencing. Various DNA viruses (including HSV,
VZV, SV40, AAV, EBV, parvoviruses and hepatitis B) and RNA
viruses (including HTLV-1 and HTLV-2, several animal retro-
viruses, poliovirus, hepatitis A, a human corona virus, human
metapneumovirus and inﬂuenza virus) were detected in cell
cultures and clinical samples.
This novel technique requires no prior sequence infor-
mation to amplify viral genomes, but nonetheless be able
to amplify at least a portion of each viral genome. It can
detect viruses in a variety of samples using only one aliquot
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of the sample per assay. These features render it ideal for
virus discovery and detection of virus in samples for which
other methods have failed. The ability of the DOP to detect
all viruses, human and zoonotic, in parallel, is also a useful
asset in the context of emerging infectious diseases, which
often are of zoonotic origin. Another application is the iden-
tiﬁcation of viral agents in immuno-compromised patients,
who often suffer from unusual infections. Moreover, generic
detection of viral agents maybe useful in assuring the safety
of regulated products such as cell culture based vaccines.
doi:10.1016/j.ijid.2008.05.1337
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Molecular biology has become an integral part of the diag-
nosis of infectious diseases. Recently, quantitative real-time
PCR (QPCR) methods have been developed for the diagnosis
of a wide range of infectious diseases. The use of QPCR as
a tool for diagnostic virological and viral research laborato-
ries has greatly increased in recent years. It often replaces
conventional PCR and amplicon detection systems which are
more complex and laborious, with a higher risk of amplicon
carry-over contamination.
The new QPCR methods presented here utilize broadly
targeted primers and probes for rational and sensitive
detection and quantiﬁcation of variable RNA viruses. They
take advantage of the dual properties, both RNA and DNA
dependent DNA polymerase activities, of the rTth ther-
mostable polymerase, and thermolabile UNG with dUTP to
protect against inadvertent contamination of samples with
amplimers.
Specimen collection and delivery to the laboratory with-
out delay and with minimal losses are vital components
for reliable RNA measurements in a diagnostic service.
62 Cerebrospinal ﬂuid, 71 stool specimens & 203 human
nasopharyngeal aspirates involved in this study.
We describe broadly targeted QPCRs which use several
alternative conserved sequences. The assays developed will
be useful tools for performing infection surveys. The devel-
opment of broadly reactive QPCRs assays for RNA viruses was
challenging due to the extensive genetic diversity among
the different viruses. The assays in the present study were
able to detect all or most of the intended target viruses in
less than 3 hours, to achieve the ideals broad targeting, high
sensitivity, high speciﬁcity and quantitative results.
The technologies described in this study have common
features. They are a platform for further development
of diagnostic tools for screening and detection of viruses
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Single-stranded DNA fragments attain a number of con-
formational forms which may be separated by electrophore-
sis in native polyacrylamide gels giving a characteristic
pattern of electrophoretic bands. Minute sequence changes
(e.g. point mutations) may have signiﬁcant effect on elec-
trophoretic pattern of single-stranded DNA. Changes of gel
temperature during electrophoresis increase the sensitivity
of mutation detection in PCR products; this technique, a
modiﬁcation of SSCP technique, was named MSSCP (where
M stands for ‘‘multitemperature’’). This method modi-
ﬁed in our laboratories was applied for characterization
of inﬂuenza A cDNA fragments. A series of primers were
synthesized after the comparison of the hemagglutinin, neu-
raminidase and PB2 gene sequences of different origin. PCR
reactions were run using these primers and the products
were denatured. Single-stranded DNA fragments were sub-
jected to MSSCP electrophoresis where, after silver staining,
they gave characteristic ssDNA band patterns. This tech-
nique was applied to analyse hemagglutinin, neuraminidase
and PB2 gene fragments from recent isolates of avian ﬂu.
Minor differences within a serotype were detected which
makes the MSSCP technique a valuable tool for quick pre-
liminary characterization of inﬂuenza variants.
doi:10.1016/j.ijid.2008.05.1339
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Evaluation of Two Commercial Enzyme Immunoassays for
Rapid Detection of Noroivrus Antigen in Human Stool
Specimens
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Two commercial enzyme immunoassay kits: Ridascreen
Norovirus (3rd generation, R-Biopharm AG, Germany) and
Denka Seiken NV-AD (II) (Denka Seiken Co. Ltd., Tokyo,
Japan), that detect norovirus antigen in human stool speci-
mens, were evaluated to access whether they can be used in
routine diagnosis and outbreak investigation. A total num-
ber of 154 stool specimens collected from young children
from primary schools who suffered from acute gastroenteri-
tis were tested for norovirus antigen by the two ELISA kits
and by Real Time-PCR method. The Ridascreen kit revealed
a high sensitivity of 90.8%, a speciﬁcity of 95.5%, and an
efﬁciency of 95.2%. The Denka ELISA kit had a sensitivity of
72.3%, a speciﬁcity of 82.9%, and an efﬁciency of 87.0%. The
precision for Ridascreen is 1.6% for positive control whereas
it is 7.7% for Denka kit. These ﬁndings indicate these ELISA
kits may be used as alternative methods for screening of
norovirus in stool specimens.
doi:10.1016/j.ijid.2008.05.1340
